Cancer Articles, News & Research Info | Treatment & Drug Trials - Cancer Therapy Advisor

Top News

Abemaciclib Provides Long-Term Benefits in HR+, HER2- Breast Cancer

Trastuzumab Deruxtecan Improves PFS and OS in HER2+ Advanced Breast Cancer

Adding Everolimus to Adjuvant ET Does Not Improve Survival in High-Risk HR+/HER2- Breast Cancer

Adding Chemo to Endocrine Therapy Increases Cognitive Impairment in HR+, HER2- Breast Cancer

DFS Improved With AIs vs Tamoxifen in HR+, HER2- Early Breast Cancer

Investigating Racial Disparities in HR+, HER2- Breast Cancer

Legalization of Medical Marijuana Linked to Reduction in Opioid Rx for Cancer Patients

2013 to 2017 Saw Significant Drop in US Melanoma Mortality Rates

CVD Risk Increased for Adolescent, Young Adult Cancer Survivors

Complications Requiring Reoperation Common After Radical Cystectomy

FDA Rejects Omburtamab for Neuroblastoma After Disappointing Panel Vote

Tecentriq Indication for Previously Untreated Advanced Bladder Cancer Withdrawn

EDITORIAL ADVISORY BOARD

Barbara Ann Burtness, MD

Steven Cohen, MD

E. David Crawford, MD

Don S. Dizon, MD, FACP

Jeffrey M. Farma, MD

Neal D. Shore, MD, FACS

Mark A. Socinski, MD

Mario Sznol, MD

Click here for complete profiles

Featured

SABCS 2022

News from the San Antonio Breast Cancer Symposium 2022
Recognizing Radiation Therapy as Both Cause and Treatment for Cancer Pain

Estimates vary, but research has suggested that roughly 60% of patients undergoing cancer therapy experience pain.
Clinical Challenge: Vomiting and Testicle Pain

A patient with a history of HIV presents to the ED with a 3- to 4-week history of vomiting and testicle pain. Can you make the diagnosis?
Medicine vs Food: The Patient Care Dilemma of Financial Toxicity

Physicians are calling on colleagues to bring up the cost of care and its potential impact when discussing treatment options with patients.
SNO 2022

News from the Society for Neuro-Oncology 27th Annual Meeting
Up to 10% of Early-Onset mCRC Cases May Be Driven by Undiagnosed IBD

As many as 10% of early-onset metastatic colorectal cancer cases may be attributable to undiagnosed inflammatory bowel disease, a study suggests.
Duration of ET Tied to Benefit in DCIS, but Young Patients May Reject ET

Two new studies shed light on the complexity of preventing subsequent breast cancer events in patients with ductal carcinoma in situ.
SAFER Ukraine: A Global Effort to Evacuate Children With Hematologic Cancers From Ukraine

The SAFER program is helping Ukrainian children with cancers and other blood disorders to continue their therapy in Ukraine or at centers in Europe and North America.
IKCS North America 2022

News from IKCS North America 2022

More Features

Crisis in Oncology Research Demands Urgent Action, Stakeholders Say

By

Alan P. Lyss, MD

Breast Implant-Associated Cancers: What Providers and Patients Need to Know

By

Tori Rodriguez, MA, LPC, AHC

Office discussion

How an Ethics Consultant Can Help Resolve Conflicts

By

David Alfandre, MD, MSPH

Son caring for sick father

The Role and Responsibilities of Surrogate Decision Makers

By

David Alfandre, MD, MSPH

Blood sample

Blood Test Shows Promise for Detecting Cancers Without Approved Screening Tests

By

Alan P. Lyss, MD

More Features »

Fact Sheets

Vaccination

Fact Sheet: COVID-19 Vaccine Considerations for Patients With Cancer

COVID-19 testing

What to Expect: Enrolling on a Cancer Clinical Trial During COVID-19